SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Cash flow

0 Followers

SynAct Pharma AB Cash Flow

DE:8F8's free cash flow for Q was kr-22.31M. For the fiscal year, DE:8F8's free cash flow was decreased by kr-52.56M and operating cash flow was kr-22.31M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
kr -117.55Mkr -117.56Mkr -65.00Mkr -33.24Mkr -16.63Mkr -24.21M
Investing Cash Flow
kr 27.00Kkr 27.00Kkr -6.00Kkr -93.00Kkr 0.00kr 0.00
Financing Cash Flow
kr 200.71Mkr 200.71Mkr 74.32Mkr 44.72Mkr 13.00Mkr 20.76M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 266.42Mkr 108.25Mkr 24.00Mkr 14.55Mkr 3.50Mkr 7.07M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-kr 228.94Mkr 80.00Mkr 49.76Mkr 0.00kr 22.35M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
kr -117.55Mkr -117.56Mkr -65.00Mkr -33.24Mkr -16.63Mkr -24.21M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

SynAct Pharma AB Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis